Table 4.
Right Eye | N (%) | Treatment, N (Col %) | ||
Visit | Score |
All Patients
N = 30 |
Nextal
N = 15 |
Respilac
N = 15 |
Screening (day −3) | 1 | 18 (60.0) | 11 (73.3) | 7 (46.7) |
2 | 11 (36.7) | 3 (20.0) | 8 (53.3) | |
3 | 1 (3.3) | 1 (6.7) | 0 | |
Day 0 | 1 | 16 (53.3) | 8 (53.3) | 8 (53.3) |
2 | 13 (43.3) | 6 (40.0) | 7 (46.7) | |
3 | 1 (3.3) | 1 (6.7) | 0 | |
Day 7 | 1 | 14 (46.7) | 4 (26.7) | 10 (66.7) |
2 | 16 (43.3) | 11 (73.3) | 5 (33.3) | |
3 | 0 | 0 | 0 | |
Day 14 | 1 | 19 (63.3) | 6 (40.0) | 13 (86.7) |
2 | 11 (36.7) | 9 (60.0) | 2 (13.3) | |
3 | 0 | 0 | 0 | |
Day 21 | 1 | 18 (60.0) | 5 (33.3) | 13 (86.7) |
2 | 12 (40.0) | 10 (66.7) | 2 (13.3) | |
3 | 0 | 0 | 0 | |
Day 24 | 1 | 17 (56.7) | 4 (26.7) | 13 (86.7) |
2 | 12 (40.0) | 10 (66.7) | 2 (13.3) | |
3 | 1 (3.3) | 1 (6.7) | 0 | |
Left Eye | N (%) | Treatment, N (Col %) | ||
Visit | Score |
All Patients
N = 30 |
Nextal
N = 15 |
Respilac
N = 15 |
Screening (day −3) | 1 | 14 (46.7) | 6 (40.0) | 8 (53.3) |
2 | 16 (43.3) | 9 (60.0) | 7 (46.7) | |
3 | 0 | 0 | 0 | |
Day 0 | 1 | 13 (43.3) | 6 (40.0) | 7 (46.7) |
2 | 17 (56.7) | 9 (60.0) | 8 (53.3) | |
3 | 0 | 0 | 0 | |
Day 7 | 1 | 15 (50.0) | 4 (26.7) | 11 (73.3) |
2 | 15 (50.0) | 11 (73.3) | 4 (26.7) | |
3 | 0 | 0 | 0 | |
Day 14 | 1 | 18 (60.0) | 5 (33.3) | 13 (86.7) |
2 | 10 (33.3) | 8 (53.3) | 2 (13.3) | |
3 | 2 (6.7) | 2 (13.3) | 0 | |
Day 21 | 1 | 19 (63.3) | 6 (40.0) | 13 (86.7) |
2 | 10 (33.3) | 8 (53.3) | 2 (13.3) | |
3 | 1 (3.3) | 1 (6.7) | 0 | |
Day 24 | 1 | 18 (60.0) | 5 (33.3) | 13 (86.7) |
2 | 11 (36.7) | 9 (60.0) | 2 (13.3) | |
3 | 1 (3.3) | 1 (6.7) | 0 |
Right eye. Main effects: treatment, p = 0.41; time p = 1.00; interaction: treatment × time, p = 0.94. Left eye. Main effects: treatment, p = 0.34; time p = 0.99; interaction: treatment × time, p = 0.99.